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Abstract
Background: The prevalence and burden of musculoskeletal (MSK) conditions are growing around the world, and
low back pain (LBP) is the most significant of the five defined MSK disorders in the Global Burden of Disease (GBD)
study. LBP has been the leading cause of non-fatal health loss for the last three decades. The objective of this study
is to describe the current status and trends of the burden due to LBP in Brazil based on information drawn from
the GBD 2017 study.
Methods: We estimated prevalence and years lived with disability (YLDs) for LBP by Brazilian federative units, sex,
age group, and age-standardized between 1990 and 2017 and conducted a decomposition analysis of changes in
age- and sex-specific YLD rates attributable to total population growth and population ageing for the purpose of
understanding the drivers of changes in LBP YLDs rates in Brazil. Furthermore, we analyzed the changes in
disability-adjusted life years (DALYs) rankings for this disease over the period.
Results: The results show high prevalence and burden of LBP in Brazil. LBP prevalence increased 26.83% (95% UI
23.08 to 30.41) from 1990 to 2017. This MSK condition represents the most important cause of YLDs in Brazil, where
the increase in burden is mainly related to increase in population size and ageing. The LBP age-standardized YLDs
rate are similar among Brazilian federative units. LBP ranks in the top three causes of DALYs in Brazil, even though it
does not contribute to mortality.
Conclusions: Findings from this study show LBP to be the most important cause of YLDs and the 3rd leading
cause of DALYs in Brazil. The Brazilian population is ageing, and the country has been experiencing a rapid
epidemiological transition, which generates an increasing number of people who need chronic care. In this
scenario, more attention should be paid to the burden of non-fatal health conditions.
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Background
Epidemiological transitions correlate with an increase in
life expectancy of the population, a decrease in deaths
due to maternal and infectious diseases and an increase
in chronic diseases—not only related to mortality but
also to disability [1, 2]. An aging population is expected
to dramatically increase the burden of musculoskeletal
(MSK) conditions over the coming decades [3]. Data
from the Global Burden of Disease (GBD) study quanti-
fied the significant burden of MSK disorders, and its re-
cent publications have shown that the prevalence and
burden of MSK conditions are growing around the
world [4–6]. The five defined MSK disorders in the
GBD study are low back pain (LBP), neck pain, osteo-
arthritis, rheumatoid arthritis, and gout. LBP is the
most significant of these, ranking as the top cause of
years lived with disability (YLDs) in GBD 2017
MSK disorders —especially in the high-income, high-
middle-income, and middle-income countries (as de-
fined by the socio–demographic index)—and has been
the leading cause of non-fatal health loss for the last
three decades [6]. A recent series of publications
reinforce warnings about the increasing magnitude of
this problem [7–10].
Data from a Brazilian national survey in 2003 indicate
back pain as the most reported chronic disease, affecting
13.2% of the adult population [11]. In a 2013 national
health survey, 18.5% of the Brazilian population reported
chronic back pain [12]. There are also reports that back
pain is among the main factors contributing to absence
from work and early retirement in Brazil [13]. Leading
factors associated with chronic back pain in Brazil were
older age, low education level, female gender, history of
smoking, heavy physical activity at work or at home, and
being overweight or obese [12, 14].
LBP is a complex condition with multiple contributors
to both the pain and the associated disability, including
psychological factors, social factors, biophysical factors,
comorbidities, and pain-processing mechanisms [7].
There are common symptoms affecting all age groups
from children to the elderly population [15]. The high
frequency, chronicity, and resultant disability of LBP im-
pose a considerable economic burden. The financial im-
pact is cross sectoral because it increases costs in both
health care and social support systems. LBP is among
the most prevalent causes of absence from work and
medical consultations worldwide [16, 17]. However, this
disorder has not been on focus of public health pro-
grams, especially in low-income and middle-income
countries [18].
Although studies of LBP and associated factors have
been undertaken in Brazil, the burden of this disease has
not yet been well described. The objective of this study
is to describe the current status and trends of the
burden due to LBP in Brazil based on information drawn
from the GBD 2017 study.
Methods
This is a descriptive study using estimates from the Global
Burden of Diseases (GBD) 2017 study, coordinated by the
Institute for Health Metrics and Evaluation (IHME) at the
University of Washington. Data are available in the GBD
results tool [19] and the GBD compare data visualization
[20]. GBD estimates the disease burden for 359 diseases
and injuries, from 1990 to 2017, covering 195 countries
and territories. A detailed description of the robust meth-
odological approach used in the GBD analysis has been
published previously [6, 21–23]. Briefly, GBD uses three
main indicators to calculate disease burden—years of life
lost due to premature mortality (YLLs), years lived with
disability (YLDs), and the sum of YLLs with YLDs:
disability-adjusted life years (DALYs) [24]. As there is no
mortality from LBP, YLD and DALY estimates are the
same.
The input data for LBP in Brazil was mainly 12 stud-
ies, covering the period from 2002 to 2013, most of
which was conducted in the state of Rio Grande do Sul.
The full list of articles used for statistical modeling can
be found in the GBD 2017 data input sources tool [25].
To estimate prevalence, incidence, and YLDs, the Bayes-
ian meta-regression tool DisMod-MR 2.1 is used [26].
YLDs are calculated by multiplying the sequela of each
condition prevalence by the disability weight, a value at-
tributed for the health state of each sequela condition.
In addition, correction for comorbidity is performed
through the COMO (comorbidity correction) tool.
LBP is defined as low back pain (with or without pain
referred into one or both lower limbs) that lasts for at
least 1 day a year [6]. The “low back” is defined as the
area on the posterior aspect of the body from the lower
margin of the 12th ribs to the lower gluteal folds [6].
The ICD-10 codes for LBP are M54.3, M54.4, and
M54.5, and the ICD-9 code is 724 [6]. LBP is not a cause
of death, as it is an exclusively disabling condition. The
disability weights, used in the YLDs estimation, are mea-
sured on a scale from 0 to 1, with 0 as a state equivalent
to full health and 1 equivalent to death. Briefly, disability
weights were obtained from surveys conducted in several
countries from different regions. The surveys used
paired comparison questions, in which respondents con-
sidered two hypothetical individuals with different, ran-
domly selected health states and indicated which person
they regarded as healthier [27, 28]. More methodologic
detail on their application in calculating disability is
available elsewhere [6]. Table 1 from supplementary ma-
terial describes LBP sequelae classifications and the
health state with its disability weight.
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For this study, we generated the estimates of LBP
prevalence and YLDs by Brazilian federative units, sex,
and age group between 1990 and 2017. To help under-
stand the drivers of changes in LBP YLDs rates in this
period, we conducted a decomposition analysis of
changes due to total population growth, population
aging, and changes in age- and sex-specific YLD rates
for Brazil, following methodology previously used in the
GBD project, based on Das Gupta [16]. In addition, we
analyzed the position and changes in LBP YLDs and
DALYs ranking in Brazil over the same period.
To describe the degree of confidence in the indicators
and take account of uncertainties in the initial data and
subsequent calculations, GBD generates 95% uncertainty
intervals (95% UI) for its metrics, as described elsewhere
[6]. Results were expressed for all ages or were age stan-
dardized for the world population [29].
The Global Burden of Disease Study Brazil 2017 was
approved by the Ethics Committee of Federal University
of Minas Gerais (UFMG) under registration no.
628033167.00005149, according to the resolution no.
466/2012 of the Brazilian National Health Council.
Results
Prevalence
According to GBD estimates, in 2017, approximately 25
million Brazilians had LBP, with a prevalence rate per
100,000 inhabitants of 11,924.78 (95% UI 10,622.04–13,
301.04), representing an increase of 26.83% (95% UI
23.08 to 30.41) from the prevalence rate observed in
1990 (9402.31; 95% UI 8336.82–10,558.93). Figure 1
shows the prevalence rate of LBP between 1990 and
2017 for all ages by sex in Brazil. For women, LBP
prevalence rate increased by 20.14% (95% UI 16.18 to
23.87), from 10,201.89 (95% UI 9041.71–11,422.26) in
1990 to 12,256.54 (95% UI 10,941.21–13,646.53%) in
2017, and the higher increase occurred between 1995
and 2010. For men, LBP prevalence rate increased by
34.86% (95% UI 30.61 to 39.04), from 8584.69 (95% UI
7609.92–9656.17) in 1990 to 11,577.69 (95% UI 10,
269.28–12,997.60) in 2017, and increased occurred
throughout the period. The prevalence increases with
age, and it may reach 21,762.12 (95% UI 17,776.23–26,
025.14) among people aged 70 years and over (data not
shown).
Brazilian LBP prevalence rate for both sexes, all ages
by federal units in 2017 are present in Table 1. The state
with highest all ages prevalence rates is Rio Grande do
Sul (13,370.04 per 100,000; 95% UI 12,023.48-14,874.39).
Amapá had the lowest all ages prevalence rate, 10,104.26
(95% UI 8931.84-11,462.49). The southern and south-
eastern states tend to have a higher LBP prevalence than
the northern and northeast states. The difference be-
tween the state with the highest and the lowest preva-
lence was 32%.
Burden
In Brazil, there were 2,857,276.66 YLDs due to LBP in
2017, up to 80% from the 1,586,096.66 YLDs in 1990.
The age-standardized YLDs rates attributable to LBP be-
tween 1990 and 2017 had smaller changes: in women,
there was a 5% (95% UI −7.73 to −2.40) decrease from
1322.22 YLDs (95% UI 943.55–1790.30) per 100,000 in
1990 to 1255.89 YLDs (95% UI 897.80–1691.06) per 100,
00 in 2017, and in men, there was a 6.27% (95% UI 4.10
to 8.37) increase from 1157.15 YLDs (95% UI 826.96–
1568.43) per 100,000 in 1990 to 1229.68 YLDs (95% UI
876.64–1668.23) per 100,00 in 2017 (Fig. 2a). YLDs rates
Fig. 1 Brazilian low back pain prevalence rate from 1990 to 2017 for all ages by sex
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for LBP have growth between the ages of 5–9 to 65–69
years, reaching 2353.91 YLDs (95% UI 1483.59–3529.19)
per 100,000. The ages at which the YLD burden is
greater between 75-79 years (Fig. 2b). After this age, the
LBP burden reduces slightly.
Figure 3 shows the decomposition analysis of the
change of YLDs in Brazil due to LBP between 1990 and
2017. Population growth accounted for an increase of
42%, aging of the population accounted for an increase
of 40%, and changes in the underlying age- and sex-
standardized rates of YLDs accounted for a 1% decrease
in the absolute number of YLDs due specifically to LBP
over the period.
According to Table 1, southern and southeastern
states tend to have higher LBP YLD rates, and northern
states tend to have lower values. The all-ages YLDs rates
in Brazil by federative units show a higher burden in the
states of Rio Grande do Sul, São Paulo, and Paraná, and
a lower all ages YLDs rates in Amapá, Maranhão, and
Roraima. Nonetheless, when YLDs rates are age-
standardized, the estimates are similar between the
states. Rio Grande do Sul is the state with the highest
age-standardized burden of LBP, with 1300.04 (95% UI
927.98-1750.78) YLDs per 100,000, and Rio de Janeiro is
the state with the lowest age-standardized YLDs rate,
1159.64 (95% UI 815.81-1582.42) per 100,000, and the
relative difference between them is 12%. The percentage
change in age-standardized YLDs rate from 1990 to
2017 was similar in almost all states, Rio Grande do Sul
had the highest increase, 4.02% (95% UI −1.04 to 10.15),
and Rio de Janeiro was the only one who showed a re-
duction in the period (−10.52% 95% UI −14.82 to −5.86).
Fig. 2 Low back pain YLDs rates per 100,000 by sex in Brazil, 2017. a Age-standardized YLDs per 100,000. b YLDS per 100,00 by age groups
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Additionally, the difference between the Brazilian state
with the lowest rate of YLDs age standardized, Rio de
Janeiro, and the global estimates (810.34 YLDs per 100,
000; 95% UI 582.41−1089.10) is 43% (Table 1).
In Brazil, LBP was the major cause of disability in
2017, the age-standardized rate was 1243.58 (95% UI
888.04-1,681.16) YLDs/100,000. For comparison, it is
38% higher than the second cause, headache disorders
(898.54, 95% UI 587.46-1287.30). Brazilian LBP DALYs
ranking for both sexes, all ages, went from the ninth to
fifth position between 1990 and 2007, and ranked third
position in GBD diseases in 2017. Figure 4 shows this
Fig. 3 Decomposition analysis of LBP YLDs (thousands) change from 1990 to 2017
Fig. 4 DALYs rank rate per 100,000 (both sexes and all ages) in Brazil, 1990–2007–2017. COPD, chronic obstructive pulmonary disease
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change and allows comparing the position of LBP in re-
lation to other diseases that contribute significantly to
mortality rates; for example, it is ranked above causes
such as stroke and diabetes.
Discussion
This study highlights the high prevalence and burden of
LBP in Brazil. We found that LBP prevalence increased
by 26.82% (95% UI 23.08 to 30.41) between 1990 and
2017 and tends to be higher among southern and south-
eastern Brazilian states. However, it appears to be in-
creasing more between northern, northeastern, and
midwestern federative units in the last 27 years. LBP rep-
resents the most important cause of YLDs in Brazil,
remaining in the first place of rankings of YLDs for
GBD diseases in this 27-year period. Although the in-
crease in this burden is mainly related to increases in
population size and aging. As with prevalence, GBD also
estimated higher rates of YLDs for the southern and
southeastern states, but the increase in the period 1990-
2017 is similar in almost all states, except for Rio de
Janeiro that had a decrease. Brazilian age-standardized
YLDs rates are similar between states and higher than
global estimates. LBP is a disease that does not lead to
death. Hence, it does not contribute to years of life lost
(YLL), and 100% of all LBP DALYs are due to YLDs.
The chronicity of LBP and the fact that it begins at
younger ages causes the burden for LBP to rank in the
top three causes of DALYs in Brazil.
The Brazilian National Health Survey (PNS) 2013
found a prevalence of back pain of 18.5% in persons 18
years or older, higher than GBD estimates [12]. The
PNS evaluated chronic pain with the question: “Do you
have a chronic back problem, such as chronic back or
neck pain, LBP, sciatica, vertebrae or disc problems?”
but did not delimit the period of the pain occurrence,
while the GBD assessed prevalence in last year (at least
1 day in last 12 months) only for LBP [12]. This differ-
ence in classifications could in part explain the differ-
ences between GBD prevalence estimates and PNS.
Furthermore, results from the PNS were not included in
the data selection process used to generate GBD esti-
mates; that is, the real values may be even larger, which
only reinforces the magnitude of the problem.
Although in this study the prevalence rate of LBP
seems to be higher among women, there was no statisti-
cally significant difference in relation to men’s rates. A
higher prevalence of LBP in women has been observed in
some previous studies [12, 30]. In the literature, this has
been attributed to the greater awareness of women about
the symptoms and signs of diseases [14, 31]; factors such
as performing housework in greater intensity in non-
ergonomic position and repetitive tasks [31]; differences in
anatomical and functional characteristics, such as smaller
height, less muscle mass, less bone mass, joints more fra-
gile, and less adapted to strenuous physical effort, may re-
sult in more overload in the back [31]; pregnancy factors,
like hormones, weight increase, inadequate posture during
pregnancy, postural inadequacies when breastfeeding, the
child’s weight, and other factors [31].
Age is one of the most common risk factors for MSK
conditions. The ratio of older to younger people will
continue to increase throughout the world. Additionally,
the number of people who are obese, which is now one
of the major risk factors for MSK conditions, is expected
to increase more dramatically in low-income and
middle-income countries over the coming two decades
[8]. Data from a Brazilian national survey shows that fac-
tors associated with a higher prevalence of chronic back
pain in both sexes, adjusted by age and education, were
increasing age; low education level; smoking history;
high salt intake; heavy activity at work or at home, and
the increase in the time spent on these activities; being
overweight or obese; having chronic diseases; and poor
health assessments [12]. The main risk factors for LBP
according to the GBD study are occupational ergonomic
factors, smoking, and high body mass index [26].
LBP is the largest cause of MSK disability in Brazil [6]
and a large proportion of those affected are in their most
productive years of life. This can have a major effect on
a family’s livelihood as the ability to be productive in
these years is often required to support younger and
older family members [3]. Chronic back pain is one of
the most commonly reported complaints by the adult
population, causing disability, reduced functionality, ab-
sence from work, and the most common cause of social
security pension disability claims and early retirements
in Brazil [13]. In addition to indirect costs, related to
lower productivity, time away from work, and expenses
resulting from sick leaves and early retirements, the dir-
ect costs are quite significant—tests, medications, phys-
ical therapy, and hospitalizations [31]. Between 1995 and
2014, expenditure on spinal surgery in Brazil increased
by 540% (from R$27.1 million to R$146.5 million) [8].
Nevertheless, few studies exist for these disabling health
conditions.
Progress in reducing the impact of disabling condi-
tions has been much slower—the focus remains on redu-
cing mortality rather than the main causes of disability.
The slower progress in addressing non-fatal compared
with fatal health outcomes and aging of populations
make YLDs an increasingly important component of glo-
bal DALYs. In some countries with advanced aging,
YLDs already make up more than half of the total bur-
den in DALYs [6].
The growing number of people affected by MSK con-
ditions in low- and middle-income countries, including
Brazil, is of great concern. Health services are not
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prepared to meet such demand. A paradigm shift is ur-
gently needed if we are to alleviate the increasing global
burden of non-fatal diseases, such as MSK conditions,
and reduce the number of avoidable disabilities [3].
Our findings call for the integration of prevention and
control programs for MSK disorders within health system
programs, which may reduce the severity of disabilities.
Interventions should include control of known risk factors
especially through health education and awareness; ergo-
nomic factors in occupational health and safety assess-
ments; provide evidence-based early diagnosis and
treatment; rehabilitative care and community programs to
increase knowledge of relevant risk and protective factors.
A recent meta-analysis of population-based interven-
tions to prevent LBP concluded that combined strength-
ening with stretching or aerobic exercises two to three
times per week can be recommended to prevent LBP
[32]. Greater exercise appears to prevent incident epi-
sodes of LBP, and the effect may be greater when exer-
cise is combined with self-care education [33]. Greater
effort by the Brazilian National Health System (SUS: Sis-
tema Único de Saúde) and private health systems to
stimulate the regular practice of physical activity and
stretching should be pursued. The relative lack of studies
on the prevention and management of this condition also
calls for a greater priority in research funding for investi-
gation of the prevention and management of LBP. In
addition, it is necessary to improve the collection of health
data to monitor trends and efficacy of interventions.
There are inherent limitations in estimating LBP, be-
cause their measurement is fully dependent on self-
reported metrics and the recognition of the disease by
the individual depends on the degree of perception, fre-
quency of signs and symptoms. To mitigate this, the
GBD 2017 study makes adjustments for variations in re-
call period, anatomical location, minimum duration of
episodes, and the extent to which the condition limits
activity. Also, there are limitations inherent to the GBD
process estimation. One of them is the absence of stud-
ies about LBP prevalence in all Brazilian states. Rio
Grande do Sul was the state which presented the highest
rates for prevalence and YLDs for LBP, and also was the
one with the largest number of studies. It is possible that
estimates may be under assessed in other states. To miti-
gate this other limitation, GBD uses complex modeling
to get closer to real estimates.
Conclusion
Findings from this study show LBP to be the most im-
portant cause of YLDs and the 3rd leading cause of
DALYs in Brazil. The Brazilian population is aging, and
the country has been experiencing a rapid epidemio-
logical transition, which generates an increasing number
of people who need chronic care. In this scenario, more
attention should be paid to the burden of non-fatal
health outcomes.
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